Cited by 753Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes

Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM

Reaven, Gerald M, Hollenbeck, Clarie, Jeng, Chii-Yang, Wu, Min Shung, Chen, Yii-Der Ida·1988·Diabetes

Abstract

Fasting and postprandial plasma glucose, free fatty acid (FFA), lactate, and insulin concentrations were measured at hourly intervals for 24 h in 27 nonobese individuals—9 with normal glucose tolerance, 9 with mild non-insulin-dependent diabetes mellitus (NIDDM, fasting plasma glucose < 175 mg/dl), and 9 with severe NIDDM (fasting plasma glucose > 250 mg/dl). In addition, hepatic glucose production (HGP) was measured from midnight to 0800 in normal individuals and patients with severe NIDDM. Plasma glucose concentration was highest in patients with severe NIDDM, lowest in those with normal glucose tolerance, and intermediate in those with mild NIDDM (two-way ANOVA, P < .001). Variations in plasma FFA and lactate levels of the three groups were qualitatively similar, with lowest concentrations seen in normal individuals, intermediate levels in the group with mild NIDDM, and the highest concentration in those with severe NIDDM (two-way ANOVA, P < .001). Of particular interest was the observation that plasma FFA concentrations were dramatically elevated from midnight to 0800 in patients with severe NIDDM. The 24-h insulin response was significantly increased in patients with mild NIDDM, with comparable values seen in the other two groups. Values for HGP fell progressively throughout the night in normal individuals and patients with severe NIDDM, despite a concomitant decline in plasma glucose and insulin levels. Although the magnitude of the fall in HGP was greater in NIDDM, the absolute value was significantly (P < .001) greater than normal throughout the period of observation. These results demonstrate that there are differences in substrate level between individuals with normal glucose tolerance and patients with NIDDM and differing degrees of glucose intolerance, unrelated to ambient insulin level, and these changes persist over 24 h.

Integrity signals

Registry

Crossref · 10.2337/diab.37.8.1020

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The metabolic derangements of Type 2 diabetes include an increase in plasma NEFA concentrations, which produce deleterious effects on insulin-sensitive tissues and the beta cell.

    “The metabolic derangements of Type 2 diabetes include an increase in plasma NEFA concentrations [145], which has been shown to produce deleterious effects on the insulin-sensitive tissues and the beta cell.”
  • Non-diabetic obese and type 2 diabetic individuals have day-long elevation of plasma free fatty acid concentration that fails to suppress normally after a mixed meal or oral glucose load.

    “Nondiabetic obese and type 2 diabetic individuals are characterized by day-long elevation in the plasma FFA concentration, which fails to suppress normally after ingestion of a mixed meal or an oral glucose load [60].”

    From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [60]

  • Increased hepatic de novo lipogenesis precedes the development of adipose tissue insulin resistance, which subsequently leads to increased flux of fatty acids to the liver.

    “these results suggest that increased hepatic de novo lipogenesis precede the development of adipose tissue insulin resistance, which subsequently leads to increased flux of fatty acids to the liver (16, 17).”

Cites

Still being checked.

Cited by

Sorted by citations

Authors
Reaven, G. M., Hollenbeck, C., Jeng, C.-Y., Wu, M. S., & Chen, Y.-D. I.
Affiliations
VA Palo Alto Health Care System (US)
Venue
Diabetes
Published
1988-08-01
Volume
37
Issue
8
Pages
1020-1024
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2109820048
Cited by
753
References
0
Citations by year
2026: 3 · 2025: 6 · 2024: 13 · 2023: 13 · 2022: 6 · 2021: 21 · 2020: 27 · 2019: 22 · 2018: 25 · 2017: 32 · 2016: 27 · 2015: 28 · 2014: 37 · 2013: 34 · 2012: 27
FWCI
4.05
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK30732)
  • National Center for Research Resources (RR-00070-26)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
type 2 diabetes, plasma glucose, free fatty acids, lactate, insulin response, hepatic glucose production, circadian variation, fasting blood glucose, postprandial blood glucose, glucose tolerance
MeSH terms
Blood Glucose, Circadian Rhythm, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Humans, Insulin, Lactates, Monitoring, Physiologic, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review